Key Points
- Tenet Healthcare EVP Lisa Foo sold 10,000 shares at an average price of $258.03, totaling $2.58 million. The sale reduced her ownership by 23.78%, leaving her with 32,053 shares.
- Tenet reported strong quarterly results, with EPS of $6.12 versus the $4.26 consensus and revenue of $6.04 billion, up 6.8% year over year.
- Wall Street remains broadly positive: 17 analysts rate the stock Buy and three rate it Hold, producing a “Moderate Buy” consensus and an average price target of $268.50.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) EVP Lisa Foo sold 10,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $258.03, for a total value of $2,580,300.00. Following the completion of the sale, the executive vice president owned 32,053 shares of the company's stock, valued at approximately $8,270,635.59. The trade was a 23.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Tenet Healthcare Price Performance
Tenet Healthcare stock opened at $254.88 on Friday. The stock's 50 day moving average price is $192.10 and its two-hundred day moving average price is $199.35. The stock has a market capitalization of $21.96 billion, a price-to-earnings ratio of 9.83, a PEG ratio of 0.96 and a beta of 1.27. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare Corporation has a 52-week low of $156.71 and a 52-week high of $262.68.
Tenet Healthcare (NYSE:THC - Get Free Report) last released its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. Tenet Healthcare's quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. On average, equities analysts predict that Tenet Healthcare Corporation will post 21.09 earnings per share for the current year.
Institutional Trading of Tenet Healthcare
Several institutional investors and hedge funds have recently modified their holdings of THC. Price T Rowe Associates Inc. MD lifted its holdings in shares of Tenet Healthcare by 1.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,490,350 shares of the company's stock valued at $1,488,484,000 after purchasing an additional 119,809 shares in the last quarter. Boston Partners raised its position in Tenet Healthcare by 15.7% in the 4th quarter. Boston Partners now owns 3,642,136 shares of the company's stock valued at $723,804,000 after buying an additional 494,581 shares during the last quarter. AQR Capital Management LLC lifted its stake in Tenet Healthcare by 20.3% during the 4th quarter. AQR Capital Management LLC now owns 2,256,539 shares of the company's stock valued at $448,419,000 after acquiring an additional 380,116 shares in the last quarter. Ameriprise Financial Inc. grew its stake in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company's stock worth $373,020,000 after acquiring an additional 157,109 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Tenet Healthcare in the fourth quarter valued at about $248,494,000. 95.44% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of brokerages recently commented on THC. Morgan Stanley boosted their target price on Tenet Healthcare from $254.00 to $274.00 and gave the company an "overweight" rating in a research report on Monday. Robert W. Baird boosted their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the company a "neutral" rating in a report on Tuesday. Piper Sandler set a $308.00 target price on Tenet Healthcare in a research report on Monday. KeyCorp reduced their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an "overweight" rating for the company in a research report on Friday, May 1st. Finally, Guggenheim upped their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a "buy" rating in a report on Tuesday. Seventeen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Tenet Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $268.50.
Read Our Latest Research Report on Tenet Healthcare
Tenet Healthcare Company Profile
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
